Abstract: The present application relates to compounds of Formula (I), wherein P, Q, A, B, m, n, R1, R2 and R3 are defined as in Formula (I) which are negative allosteric modulators of the metabotropic glutamate receptor subtype 7 (mGlu7) and which are useful for the treatment or prevention of neurological, ear and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGlu7 subtype of metabotropic receptors is involved. The application is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and such compositions, and to the use of such compounds for the prevention or treatment of neurological, ear and psychiatric disorders and diseases in which mGlu7 is involved.

Abstract: A method for adjusting the speed of at least one vehicle belonging to a set of at least two autonomous vehicles moving on an itinerary in a coordinated manner. Following the acquisition of event information relating to an event occurring on the itinerary, a management entity of a telecommunications infrastructure identifies at least one target vehicle based on the acquired event information and determines a control instruction for the at least one target vehicle based on the acquired event information. The entity then transmits the control instruction to the at least one vehicle.

Abstract: A method for adjusting the speed of at least one vehicle belonging to a set of at least two autonomous vehicles moving on an itinerary in a coordinated manner. Following the acquisition of event information relating to an event occurring on the itinerary, a management entity of a telecommunications infrastructure identifies at least one target vehicle based on the acquired event information and determines a control instruction for the at least one target vehicle based on the acquired event information. The entity then transmits the control instruction to the at least one vehicle.